INTERNATIONAL PATENT: TIXAPHARM AG FILES APPLICATION FOR "ANTIBODIES AGAINST CD44"

GENEVA, May 18 -- TIXAPHARM AG (BismarckstraBe 1397080 Wurzburg) filed a patent application (PCT/EP2024/081904) for "ANTIBODIES AGAINST CD44" on Nov 11, 2024. With publication no. WO/2025/099324, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GELLERT, Johanna (c/o Pentixapharm AGBismarckstraBe 1397080 Wurzburg), DANIELCZYK, Antje (c/o Pentixapharm AGBismarckstraBe 1397080 Wurzburg), BAHRKE, Sven (c/o Pentixapharm AGBismarckstraBe 1397080 Wurzburg), KEHLER, Patrik (c/o Pentixapharm AGBismarckstraBe 1397080 Wurzburg), JAKE...